Hub Group (NASDAQ: HUBG) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a top complex litigation law firm, is investigating Hub Group Inc. (NASDAQ: HUBG) (“Hub Group” or the “Company”) for potential violations of the federal securities laws.

On February 5, 2026, Hub Group announced that it would restate its financial statements for the first, second, and third quarters of 2025 due to an error that resulted in the understatement of purchased transportation costs and accounts payable. The Company disclosed that the total reduction to accounts payable and purchased transportation costs related to the identified error was $77 million for the nine months ended September 30, 2025. The Company delayed its full earnings release and stated that it is continuing to assess the potential impact on its financial statements for 2023 and 2024, indicating the scope of the accounting errors may extend beyond 2025.

“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said attorney Andrea Farah, Lowey Dannenberg, P.C. partner and head of the firm’s securities practice.

If you suffered a loss of more than $50,000 in Hub Group securities, and wish to participate, or learn more about your eligibility, click here, or contact our attorneys Andrea Farah ([email protected]) at (914)733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914)733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  [email protected] 

SOURCE: Lowey Dannenberg



NRSInsights’ April 2026 Retail Same-Store Sales Report

April same-store sales increased 3.9% year-over-year 

The average price paid for the top 500 items in April increased 2.2% year-over-year

NEWARK, N.J., May 08, 2026 (GLOBE NEWSWIRE) —  NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative retail same-store sales results for April 2026.

As of April 30, 2026, the NRS retail network comprised approximately 39,300 active terminals nationwide, scanning purchases at approximately 34,100 independent retailers, including convenience stores, bodegas, liquor stores, grocers, and tobacco and sundries sellers, predominantly serving urban consumers.


April Highlights

(Same-store sales, unit sales, transactions, and average price data refer to April 2026 and are compared to April 2025 unless otherwise noted. All comparisons are provided on a “per calendar day” basis to remove from consideration variability in the number of days per month or three-month period.)

  • SALES
    • Same-store sales increased 3.9% year-over-year. In the previous month (March 2026), same-store sales increased 2.9% year-over-year.
    • Same-store sales increased 1.7% compared to the previous month (March 2026). Same-store sales in March 2026 increased 4.3% compared to the previous month (February 2026).
    • For the three months ended April 30, 2026, same-store sales increased 3.2% compared to the corresponding three months a year ago.
  • UNITS SOLD
    • Units sold increased 0.5% year-over-year. In the previous month (March 2026), units sold decreased 1.2% year-over-year.
    • Units sold increased 1.3% compared to the previous month (March 2026). Units sold in March 2026 increased 4.0% compared to the previous month (February 2026).
  • BASKETS (TRANSACTIONS) PER STORE
    • Baskets decreased 0.3% year-over-year. In the previous month (March 2026), baskets decreased 0.4% year-over-year.
    • Baskets increased 2.9% compared to the previous month (March 2026). Baskets in March 2026 increased 6.5% compared to the previous month (February 2026).
  • AVERAGE PRICES
    • A dollar-weighted average of prices for the top 500 items purchased in April 2026 increased 2.2% year-over-year, more than the 1.4% year-over-year increase in March 2026.


Commentary from Brandon Thurber


(VP, Data Sales & Client Success at NRS)

“Same-store sales accelerated in April, increasing 3.9% year-over-year compared to the 2.9% year-over-year growth recorded in March. The growth was powered by an increase in dollar sales per basket, which more than compensated for a slight decrease in transactions, continuing a long-term trend of increasing average per-visit spend.

“Turning to category performance, prepared cocktails and espresso experienced the strongest growth, and coconut water, sparkling water, and smokeless tobacco each posted strong double-digit gains. Rolling papers, frozen novelty, and wine-based cocktails also continued their steady climbs.

“Regionally, Raleigh Durham led the pack with a double-digit year-over-year sales increase while Los Angeles, Washington DC and Miami / Ft. Lauderdale all registered slight decreases.

“Our measure of inflation, reflecting the relative prices of the 500 top-selling products within our network, remained subdued at 2.2%.”


NRSInsights Reports

The NRSInsights monthly Retail Same-Store Sales Reports are intended to provide timely topline data reflective of sales at NRS’ network of independent, predominantly urban, retail stores.  

Same-store data comparisons of April 2026 with April 2025 are derived from approximately 232 million transactions processed through the approximately 25,300 stores on the NRS network that scanned transactions in both months. Same-store data comparisons of April 2026 with March 2026 are derived from approximately 283 million transactions processed through approximately 33,000 stores.

Same-store data comparisons for the three months ended April 2026 with the year-ago three months are derived from approximately 643 million transactions processed through stores that scanned transactions in both three-month periods.


NRS POS Platform

The NRS platform predominantly serves small-format, independent, retail stores nationwide including convenience stores, bodegas, liquor stores, grocers, and tobacco and sundries sellers. These independent retailers operate in all 50 states and the District of Colombia, including 206 of the 210 designated market areas (DMAs) in the United States, and in Canada.   During April 2026, NRS’ POS terminals processed $2.2 billion in sales (+13% year-over-year) across 145 million transactions.


About National Retail Solutions (NRS):

National Retail Solutions operates a leading point-of-sale (POS) terminal-based platform and digital payment processing service for independent retailers nationwide. Retailers utilize NRS offerings to process transactions, effectively manage their businesses, and integrate with leading online order and delivery platforms. Consumer packaged goods (CPG) suppliers, brokers, analytics firms, and advertisers access the terminal’s digital display network to reach these retailers’ predominantly urban, multi-cultural shopper base, and to harness transaction data-based learnings to identify growth opportunities and measure both execution and returns on marketing investment. NRS is a subsidiary of IDT Corporation (NYSE: IDT).

All statements above that are not purely about historical facts, including, but not limited to, those in which we use the words “believe,” “anticipate,” “expect,” “plan,” “intend,” “estimate,” “target” and similar expressions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment of what may happen in the future, actual results may differ materially from the results expressed or implied by these statements due to numerous important factors. Our filings with the SEC provide detailed information on such statements and risks, and should be consulted along with this release. To the extent permitted under applicable law, IDT assumes no obligation to update any forward-looking statements.


NRSInsights Contact:


Brandon Thurber
VP, Data Sales & Client Success at NRS
National Retail Solutions
[email protected]


IDT Corporation Contact:

Bill Ulrey
[email protected]

# # #



Merit Medical to Participate in the Bank of America Healthcare Conference

SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America 2026 Health Care Conference, to be held in Las Vegas, Nevada, May 12-14, 2026.

The management team will participate in a fireside chat session on Tuesday, May 12th at 3:00 pm Pacific Time / 6:00 pm Eastern Time.

A live audio webcast of the fireside chat will be accessible under the “Events” section of the Company’s investor relations website at Investor Events and Presentations – Merit Medical. A replay of the fireside chat will be available on this same website for approximately 90 days.

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.

CONTACTS 

PR/Media Inquiries 
Sarah Comstock

Merit Medical 
+1-801-432-2864 | [email protected] 

Investor Inquiries 
Mike Piccinino, CFA, IRC 
ICR Healthcare 
+1-443-213-0509 | [email protected]



Sono Group N.V. Completes Exit from Legacy Solar Operations

Transfer of Sono Motors to Its Management Team Marks Full Completion of the Strategic Transition Announced in March 2026; Sono Group Currently Operates as a Focused Digital Asset Treasury Company

Munich, Germany, May 08, 2026 (GLOBE NEWSWIRE) — Sono Group N.V. (Nasdaq: SSM) (hereafter referred to as “Sono” or the “Company”) today announced the completion of a decisive milestone in its ongoing strategic transformation: the formal transfer of its now former subsidiary Sono Motors GmbH (“Sono Motors”) to companies controlled by Sono Motors’ own management team. The transaction closed and took legal effect on May 4, 2026, bringing to a close the solar exit the Company announced in March. Sono Group holds no further equity interest in Sono Motors and carries no ongoing operational obligations to the business.

With this transaction complete, the Company turns fully to the Treasury Strategy: acquiring Bitcoin and generating yield through a covered-call approach under its institutional ISDA framework. The proceeds of the Company’s March 2026 financing were deployed into Bitcoin acquisition immediately upon receipt, capital that would otherwise have been partially absorbed by legacy solar operations. With the exit complete, there is no longer a competing claim on that capital.

The legacy solar business was transferred to Sono Motors’ two managing directors, Denis Azhar and Jan Schiermeister, who acquired it directly, together with the technology and the team they led. The brand’s solar heritage and the people behind it remain in capable hands. Sono Group retains an irrevocable, royalty-free license to continue operating under the Sono name for its stock exchange listing and securities trading.

Sono Group currently operates as a digital asset treasury company and will continue to evaluate opportunities to build long-term shareholder value as its strategy develops.

“I want to thank the Sono Motors team: what Denis, Jan and their colleagues built earned real industry recognition, and I’m glad it passes to people who believe in it. For Sono Group, the transformation we announced in March is now complete. We are focused on execution and on delivering results for our shareholders,” said Kevin McGurn, Managing Director and CEO of Sono Group N.V.

Full details of the transaction, including the Share Purchase and Transfer Agreement, are set forth in the Company’s Amendment No. 1 on Form 8-K/A filed with the U.S. Securities and Exchange Commission on May 6, 2026, available at www.sec.gov and on the Company’s investor relations website at ir.sonomotors.com.

ABOUT SONO GROUP N.V.

Sono Group N.V. (Nasdaq: SSM) is a Netherlands-incorporated company listed on the Nasdaq Capital Market, currently operating as a digital asset treasury company. The Company’s Treasury Strategy is centered on the acquisition of Bitcoin and the generation of structured yield through an institutional covered-call approach under an ISDA Master Agreement framework. For more information about Sono Group N.V. visit sonogroupnv.com. Follow us on social media: LinkedIn, Facebook, BlueSky, Truth Social, and X.

FORWARD-LOOKING STATEMENTS

This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding the consummation of transactions as part of the Treasury Strategy, including their timing and the expected cash flow and the use of proceeds therefrom; the receipt of any required shareholder approvals; the projected operational and financial performance of the Company and its subsidiaries, including the Company following implementation of the Treasury Strategy; the Company’s product offerings and developments and business plans; and the Company’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future revenue and the business plans of the Company’s management team, including the pursuit of the Treasury Strategy. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release  are based on certain assumptions and analyses made by the management of the Company considering their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the consummation and timing of any transactions as part of the Treasury Strategy, and the cash flow to the Company therefrom; the occurrence of any uncured event of default or any event, change or other circumstance that could give rise to the termination of the Company’s ISDA Master Agreement relating to the Treasury Strategy; the outcome of any legal proceedings that may be instituted against the Company; risks associated with the Treasury Strategy replacing the former plans and operations of the Company including the legacy solar operations; potential difficulties in employee retention as a result of the Treasury Strategy; whether the Company will be able to maintain compliance with the continued listing standards of The Nasdaq Stock Market LLC or comply with the initial listing standards of another national securities exchange; the ability of the Company to service or otherwise pay its debt obligations; market acceptance of the Company’s product offerings; that the Company will have sufficient capital to operate as anticipated; the demand for the Company’s products; and global supply chains and legislative, regulatory and economic developments in general. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as may be required under applicable securities laws.

ADDITIONAL INFORMATION AND WHERE TO FIND IT

In connection with the solicitation of the ratification by the Company’s shareholders of the engagement by the Company in the Treasury Strategy, the Company intends to file with the Securities and Exchange Commission (the “SEC”) a proxy statement on Schedule 14A (the “Proxy Statement”) relating to an extraordinary general meeting of the Company’s shareholders to be held for the purpose of ratifying the Company’s engagement in the Treasury Strategy (the “Special Meeting”). This press release  is not a substitute for the Proxy Statement or any other document that the Company may file with the SEC or send to the Company’s shareholders in connection with the Special Meeting. This press release  does not contain all of the information that should be considered in respect of the matters to be noticed for the Special Meeting in the Proxy Statement, and additional information will be set forth in the Proxy Statement when it becomes available. Shareholders of the Company are urged to read all relevant documents filed with the SEC, including the Proxy Statement, as well as any amendments or supplements to these documents, carefully when they become available. Promptly after filing its definitive Proxy Statement with the SEC, the Company will mail the definitive Proxy Statement and a proxy card to each shareholder of the Company entitled to vote at the Special Meeting as of a record date to be established for voting at the Special Meeting.
Shareholders may also obtain a copy of the Proxy Statement, as well as other documents filed by the Company with the SEC without charge, at the SEC’s website located at www.sec.gov. In addition, shareholders may obtain a free copy of the Company’s filings with the SEC from the Company’s website at https://ir.sonomotors.com/.

PARTICIPANTS IN THE SOLICITATION

The Company and its directors, executive officers, employees and other persons may be deemed to be participants in the solicitation of proxies from the Company’s shareholders in connection with the Special Meeting under SEC rules. Shareholders may obtain more detailed information regarding the names, affiliations and interests of the Company’s executive officers and directors in the solicitation by reading the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on April 1, 2026 and the Proxy Statement when it becomes available.

NO SOLICITATION

This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the matters to be noticed in the definitive Proxy Statement when it becomes available.



Press:
[email protected] | ir.sonomotors.com/news-events
Investors:
[email protected] | ir.sonomotors.com
LinkedIn:
https://www.linkedin.com/company/sonogroupnv

Flag Ship Acquisition Corporation Enters into Letter of Intent with Bluechip & Co. Holdings

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Flag Ship Acquisition Corporation (the “Company”) (NASDAQ: FSHP), a special purpose acquisition company, today announced that it has entered into a binding letter of intent (“LOI”) with Bluechip & Co. Holdings (“Bluechip”) in connection with a proposed business combination. The letter of intent includes binding provisions regarding exclusivity and other related transaction provisions governing the parties’ negotiations during the proposed transaction process. The proposed transaction remains subject to due diligence, negotiation and execution of definitive agreements, satisfaction of customary closing conditions, and approval by the boards and shareholders of the relevant parties.

The proposed transaction contemplates that the Company or a successor public company will acquire 100% of the equity interests of Bluechip through a share exchange, merger, consolidation or otherwise. The final structure for the transaction will be evaluated and mutually agreed by the parties. Based on preliminary discussions, Bluechip’s implied equity valuation is expected to range between $300 million and $400 million. The LOI provides for an exclusive negotiation period, during which the Company will conduct comprehensive due diligence on Bluechip and the parties will negotiate the terms of a definitive merger agreement. The parties have agreed to a ninety (90) day period of mutual exclusivity, which may be extended under certain conditions as specified in the LOI.

Bluechip operates a cross-border financial services platform primarily focused on insurance-related customer acquisition, financial education, and referral services, complemented by advisory services related to U.S. capital markets transactions. Its platform is designed to connect individual clients with international insurance solutions while providing corporate clients and investors with access to U.S. capital markets opportunities across multiple jurisdictions. Bluechip’s operations are currently organized into two primary business lines: (i) cross-border insurance-related services, which represent its principal source of revenue, and (ii) U.S. capital markets advisory services.

Matthew Chen, Chairman of Flag Ship Acquisition Corporation, commented: “We are pleased to enter into this binding letter of intent with Bluechip, a platform that we believe is well-positioned in the growing cross-border financial services market. We look forward to working closely with Bluechip’s management team as we advance our due diligence and negotiate a definitive agreement.”

Ming Zhang, Chairman and Founder of Bluechip & Co. Holdings, added: “This transaction represents an exciting opportunity to accelerate our growth and expand our access to global capital markets. We believe that partnering with Flag Ship will enhance our ability to serve clients across jurisdictions and strengthen our position in both insurance-related services and capital markets advisory services.”

About Flag Ship Acquisition Corporation

Flag Ship is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities. Flag Ship’s efforts to identify a target business have not been limited to a particular industry or geographic region. Flag Ship is sponsored by Whale Management Corporation, a BVI business company with limited liability.

About Bluechip & Co. Holdings

Bluechip is an exempt company incorporated in Cayman Islands. Through its subsidiaries in Hong Kong, it operates a cross-border financial services platform primarily focused on insurance-related customer acquisition, financial education, and referral services, complemented by advisory services related to U.S. capital markets transactions.

Definitive Documentation

The parties will announce additional details regarding the proposed transaction if and when a definitive agreement is executed. No assurances can be provided as to the entry into or timing of any definitive agreement or the consummation of any transaction. Any transaction would be subject to the completion of satisfactory due diligence, the negotiation of a definitive agreement and related ancillary agreements providing for the proposed acquisition, satisfaction of the conditions negotiated therein, board and shareholder approvals, regulatory approvals and other customary conditions.

Additional Information and Where to Find It

If a definitive agreement is entered into in connection with the proposed transaction, the Company or a newly formed holding company will prepare and file a proxy statement/prospectus with the U.S. Securities and Exchange Commission (the “SEC”). The Company urges investors and securityholders to read the proxy statement/prospectus and other documents filed with the SEC when they become available, as they will contain important information regarding the proposed acquisition. The proxy statement/prospectus will be distributed to the Company’s public shareholders in connection with the Company’s solicitation of proxies for the vote by its shareholders with respect to the proposed transaction and other matters as will described therein. All SEC filings will be available free of charge at www.sec.gov.

No Offer or Solicitation

This release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of any business combination. This release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

The Company, Bluechip, and their respective directors and executive officers may be deemed participants under SEC rules in the solicitation of proxies in connection with the proposed transaction. Information regarding the Company’s directors and executive officers is available in the Company’s SEC filings. Additional details regarding the interests of persons involved in the proposed acquisition will be included in the proxy statement/prospectus when it becomes available.

Forward Looking Statements

This press release includes certain “forward-looking” statements, as that term is defined under the federal securities laws, regarding the Company and Bluechip. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The expectations, estimates, and projections of the businesses of the Company and Bluechip may differ from their actual results, and accordingly, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements generally are identified by the words or phrases such as “aspire,” “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “will be,” “will continue,” “will likely result,” “could,” “should,” “believe(s),” “predicts,” “potential,” “continue,” “future,” “opportunity,” seek,” “intend,” “strategy,” or the negative version of those words or phrases or similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, expectations with respect to the execution and delivery of a definitive agreement with respect to the proposed transaction, future performance and anticipated financial impacts of the proposed transaction, the satisfaction of the closing conditions to, and the timing of, the completion of the proposed transaction. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Many of these factors are outside of the control of the Company and Bluechip and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the negotiations and any subsequent definitive agreements with respect to the proposed transaction, and the possibility that the terms and conditions set forth in any definitive agreements with respect to the proposed transaction may differ materially from the terms and conditions set forth in the letter of intent; (2) the outcome of any legal proceedings that may be instituted against the parties following the announcement of the proposed transaction and any definitive agreements with respect thereto; (3) the inability to complete the proposed transaction, including due to failure to obtain approval of the shareholders of the Company or Bluechip or other conditions to closing; (4) the inability to obtain or maintain the listing of the Company’s securities on the Nasdaq Stock Market LLC, or another national securities exchange following the proposed transaction; (5) the risk that the proposed transaction disrupts current plans and operations as a result of the announcement and consummation of the proposed transaction; (6) the ability to recognize the anticipated benefits of the proposed transaction, which may be affected by, among other things, competition, the ability of Bluechip to grow and manage growth profitably and retain its key employees; (7) costs related to the proposed transaction; (8) changes in applicable laws or regulations; (9) risks related to Bluechip’s business, competition within the industry, potential delays or cost overruns in capital expenditures, compliance with regulatory requirements, economic and market conditions, and political or geopolitical developments; and (10) other risks and uncertainties included in documents filed or to be filed with the SEC by the Company and Bluechip. The foregoing list of factors is not exclusive.

You should not place undue reliance on any forward-looking statements. Any forward-looking statement speaks only as of the date hereof, and, except as required by law, the Company assumes no obligation and does not intend to update any forward-looking statement to reflect events or circumstances after the date hereof. Past performance by the Company and Bluechip is not a guarantee of future performance. Therefore, you should not place undue reliance on the historical record of the performance of the Company and Bluechip as indicative of future performance of an investment or the returns that the Company or Bluechip will, or are likely to, generate going forward.

For further information, please contact:

Matthew Chen | Chief Executive Officer
Phone: (212) 884-2667
Email: [email protected]



ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

Patent Expands Company’s Proprietary Surface Acoustic Wave Platform into Advanced Therapeutic Delivery Applications

TYLER, Texas, May 08, 2026 (GLOBE NEWSWIRE) — ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 17/025,969, covering a novel drug delivery system utilizing the Company’s proprietary surface acoustic wave (SAW) technology to enhance transdermal delivery of cannabinoid-based therapeutics.

The allowed claims provide broad intellectual property protection across multiple components of the combined SAW ultrasound and cannabinoid transdermal delivery system, including transdermal patch configurations, portable SAW-generating platforms, and methods shown to produce synergistic enhancement in cannabinoid absorption through the skin compared to administration via the transdermal patch alone.

Cannabinoid-based therapeutics continue to attract growing scientific, pharmaceutical, and commercial interest globally, particularly in pain management, neurology, inflammation, and chronic disease applications. ENvue Medical believes its ultrasound-based delivery platform may provide future opportunities to improve therapeutic administration and enable strategic collaborations across multiple treatment categories.

“This Notice of Allowance validates a meaningful expansion of our SAW platform into an entirely new therapeutic category,” said Doron Besser, MD, Chief Executive Officer of ENvue Medical. “We believe that the USPTO’s recognition of the synergistic effect between our ultrasound technology and cannabinoid transdermal delivery, and its determination that this combination was non-obvious, reflects the depth and breadth of our intellectual property portfolio. We believe this positions ENvue favorably as interest in cannabinoid-based therapeutics continues to grow, and we look forward to exploring the strategic opportunities this patent creates for the Company.”

The Company believes this patent allowance further reinforces the value and versatility of its proprietary SAW technology platform and highlights the potential for future applications beyond its currently marketed products.

About ENvue Medical, Inc.

ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Tel-Aviv and Nesher, Israel, the Company focuses on two distinct technology platforms:

  • ENvue™ Navigation Platform, developed and operated by ENvue Medical Inc., with offices in Arlington Heights, Illinois, and Tel-Aviv, Israel, is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA 510(k) cleared for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.
  • ENvue Medical aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation across a range of healthcare environments.
  • Acoustic-based therapeutic technologies, including PainShield® and UroShield®, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. These forward-looking statements include, but are not limited to: statements regarding the adoption and implementation of ENvue Medical’s platforms, anticipated commercial expansion, growth, scalability, and implementation of ENvue Medical’s products, the success of ENvue’s programs, market interest in the Company’s technology, and future expectations for strategic growth. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation: (i) market acceptance of the Company’s existing and new products; (ii) clinical performance and operational outcomes; (iii) delays or complications in product implementation; (iv) intense competition in the medical device industry; (v) product liability or performance issues; (vi) limitations in manufacturing or supply chain capabilities; (vii) reimbursement limitations; (viii) intellectual property protection; (ix) healthcare regulatory changes in the U.S. and abroad; and (x) the need for additional capital. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge at: www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise, except as required by law.

Investor Contact:

KCSA Strategic Communications
Valter Pinto, Managing Director
PH: (212) 896-1254
[email protected]

Media Contact:

KCSA Strategic Communications
Michaela Fawcett, Senior Account Director
PH: (978) 995-4683
[email protected]



Celsius Holdings to Participate in Upcoming Investor Conferences

Celsius Holdings to Participate in Upcoming Investor Conferences

BOCA RATON, Fla.–(BUSINESS WIRE)–Celsius Holdings, Inc. (Nasdaq: CELH) (“the Company”) today announced it will participate in the following investor conferences:

Goldman Sachs Global Staples Forum

Date: May 12, 2026

Fireside chat webcast: May 12, approximately 8 a.m. ET

Deutsche Bank Global Consumer Conference

Date: June 2, 2026

Fireside chat webcast: June 2, approximately 5:15 p.m. CEST / 11:15 a.m. ET

Jefferies Consumer Conference

Date: June 16-17, 2026

Live webcasts (where applicable) will be available in the Events & Presentations section of the Company’s investor relations website at: https://ir.celsiusholdingsinc.com/events-and-presentations/. As disclosed in our Annual Report on Form 10-K filed with the Securities & Exchange Commission (the “SEC”) on April 14, 2026, we use our website and webcasts as means of disclosing material information to the public in a broad, non-exclusionary manner, including for purposes of the SEC’s Regulation Fair Disclosure (Reg FD). Attendees are reminded to join the webcasts before the planned start time to ensure a good connection and to allow for time to complete the free registration. We intend to make replays of the webcast noted above available on our website for at least 30 days after the original conference date.

About Celsius Holdings, Inc.

Celsius Holdings, Inc. (Nasdaq: CELH) is a functional beverage company and the owner of energy drink brand CELSIUS®, health and wellness brand Alani Nu® and Rockstar Energy®. Born in fitness and pioneering the rapidly growing, better-for-you, functional beverage category, the company creates and markets leading functional beverage products. For more information, please visit www.celsiusholdingsinc.com.

Investor Relations Contact:

Paul Wiseman

[email protected]

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Food/Beverage Retail

MEDIA:

Logo
Logo

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

JERUSALEM, May 08, 2026 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”, or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that it will host a conference call and webcast on Monday, May 11, 2026 at 8:30am ET to discuss interim clinical data from the first three patients treated in its U.S. trial of Alpha DaRT for patients with recurrent glioblastoma (GBM), also known as the REGAIN (Recurrent Glioblastoma Alpha-DaRT Intratumoral Therapy) trial.

Conference Call and Webcast Details

An archived webcast will be available following the event.

About the REGAIN Study

The clinical trial is expected to enroll up to ten U.S. patients with recurrent glioblastoma not amenable for surgical resection who have undergone a prior course of central nervous system radiation. The primary objective of the study is to evaluate the feasibility and safety of the treatment, following the Company’s promising results from pre-clinical studies. Additional information about the trial can be found at https://www.clinicaltrials.gov/study/NCT06910306

About Alpha Tau Medical Ltd. 

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT

®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” “plan,” “may,” “continue,” and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to the Alpha DaRT treatment in GBM patients, including the expected patient enrollment, benefits, safety, implementation, feasibility and go to market process, and other expectations, beliefs, plans, including with respect to clinical trials, including the REGAIN study,, regulatory approvals and studies, are forward-looking. All forward-looking statements are based upon Alpha Tau’s current expectations and various assumptions. Alpha Tau believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Alpha Tau may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation: (i) Alpha Tau’s ability to receive regulatory approval for its Alpha DaRT technology or any future products or product candidates; (ii) Alpha Tau’s limited operating history; (iii) Alpha Tau’s incurrence of significant losses to date; (iv) Alpha Tau’s need for additional funding and ability to raise capital when needed; (v) Alpha Tau’s limited experience in medical device discovery and development; (vi) Alpha Tau’s dependence on the success and commercialization of the Alpha DaRT technology; (vii) the failure of preliminary data from Alpha Tau’s clinical studies to predict final study results; (viii) failure of Alpha Tau’s early clinical studies or preclinical studies to predict future clinical studies; (ix) Alpha Tau’s ability to enroll patients in its clinical trials; (x) undesirable side effects caused by Alpha Tau’s Alpha DaRT technology or any future products or product candidates; (xi) Alpha Tau’s exposure to patent infringement lawsuits; (xii) Alpha Tau’s ability to comply with the extensive regulations applicable to it; (xiii) the ability to meet Nasdaq’s listing standards; (xiv) costs related to being a public company; (xv) changes in applicable laws or regulations; and the other important factors discussed under the caption “Risk Factors” in Alpha Tau’s annual report filed on form 20-F with the SEC on March 9, 2026, and other filings that Alpha Tau may make with the United States Securities and Exchange Commission. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While Alpha Tau may elect to update such forward-looking statements at some point in the future, except as required by law, it disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing Alpha Tau’s views as of any date subsequent to the date of this press release.

Investor Relations Contact: 


[email protected]



ADI Foundation and Exodus Bring Institutional-Grade Blockchain to Self-Custody Wallets

MENA’s first institutional L2 for stablecoins and real-world assets is now natively supported in Exodus

ABU DHABI, United Arab Emirates, May 08, 2026 (GLOBE NEWSWIRE) — ADI Foundation and Exodus Movement, Inc. (NYSE American: EXOD) today announced native support for the ADI token and ADI Mainnet in Exodus, including self-custody users’ direct send-and-receive functionality for ADI. The collaboration extends ADI Chain’s institutional-grade Layer 2 infrastructure to millions of digital asset holders worldwide.

Exodus users can now send and receive ADI tokens natively within their Exodus wallet, without leaving the application or routing through third-party interfaces.

Scaling Through Exodus’s B2B Partner Network

ADI Mainnet support also rolls out across Exodus’s B2B client network, giving Exodus’s enterprise and platform partners the ability to offer ADI functionality to their own end users.

The B2B extension aligns with ADI Chain’s design as infrastructure for institutions serving millions of users. Exodus partners get a path into and out of ADI, expanding the network’s reach across multiple consumer-facing platforms.

Infrastructure Built for the Regulated Future of Finance

ADI Chain is the first institutional Layer 2 for stablecoins and tokenized real-world assets in the MENA region. Built as a zkRollup on Ethereum, it is the first network globally to deploy ZKsync’s Airbender zero-knowledge proof system in production. ADI Chain provides the settlement infrastructure for a UAE Dirham-backed stablecoin initiated by First Abu Dhabi Bank and International Holding Company (IHC), set to be regulated by the Central Bank of the UAE.

The network operates on three core pillars – Regulation, Compliance, Policy – with OpenZeppelin audits underpinning bank-grade security across the full stack. Recent partnerships with Chainlink, Brickken, and Fireblocks further reinforce the network’s growing institutional technology stack.

The Exodus integration extends this institutional foundation to the self-custody community, connecting institutional-grade infrastructure with the users who stand to benefit from it most.

“ADI Chain was designed to serve the institutions that serve billions of people. Exodus turns that pipeline into a reality, moving regulated settlement infrastructure out of the back office and into everyday wallets. That’s where real adoption begins.” – Andrey Lazorenko, CEO, ADI Foundation

“At Exodus, our work is to remove friction between users and the networks they want to use, without asking them to give up control. Adding ADI to the wallet gives its users a self-custodial path onto the network. The networks that matter reach more people when self-custody is the default.” – Kevin Wood, Director of Revenue Operations, Exodus

About ADI Foundation & ADI Chain

ADI Foundation is an Abu Dhabi-based non-profit founded by Sirius International Holding, a subsidiary of IHC, dedicated to empowering governments and institutions in emerging markets through blockchain infrastructure. The foundation’s mission is to bring one billion people into the digital economy by 2030, building on a foundation of 500+ million people already within its ecosystem reach.

ADI Chain is the first institutional Layer 2 blockchain for stablecoins and real-world assets in the MENA region, providing settlement infrastructure for a dirham-backed stablecoin initiated by IHC and FAB, licensed by the UAE Central Bank. The network operates on three pillars – Regulation, Compliance, Policy – serving governments implementing blockchain infrastructure across the Middle East, Asia, and Africa.

For more information, visit the Official Website, LinkedIn, and X.

About Exodus Movement, Inc.

Founded in 2015, Exodus Movement, Inc. (NYSE American: EXOD) is a financial technology company pioneering self-custodial finance by giving people the tools to spend, manage, and swap digital assets globally, all without giving up control. Exodus serves millions of people through its payments platform built on a simple principle: your money should be yours.

Exodus also powers crypto infrastructure for enterprise platforms serving millions of users through its business product suite. Headquartered in Omaha, Nebraska, Exodus builds financial software where individuals keep control of their assets by default. For more information, visit exodus.com.



Media Contact Information
Mohammad Rajab
[email protected]

IP Strategy Highlights Poseidon’s Launch of Numo, Expanding Supply of Rights-Cleared AI Training Data on Story

GIG HARBOR, Wash., May 08, 2026 (GLOBE NEWSWIRE) — IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”) today highlighted the early access launch of Numo, a consumer application developed by Poseidon designed to scale the collection of real-world, rights-cleared training data for AI systems.

Numo allows users to contribute real-world data through simple tasks on their mobile devices, starting with voice recordings across underrepresented languages. Each contribution is verified, rights-cleared, and licensed on-chain via Story from the moment of submission, enabling immediate commercial usability and transparent provenance.

The launch comes as AI development increasingly depends on high-quality, real-world data that cannot be sourced from the open internet. While early AI systems were trained on publicly available datasets, the next generation requires data reflecting how people speak, behave, and interact in real-world environments, creating a growing supply constraint across the industry.

Early traction for Numo highlights the scale of this demand. The platform has already reached more than 15,000 contributors, generating over 170,000 voice recordings in less than a week across just four languages, with participation continuing to accelerate. Additional languages and data collection tasks are expected to be introduced in the near term.

Numo builds on earlier validation from Poseidon’s initial data collection efforts, which demonstrated the ability to generate large volumes of distributed, human-sourced data at scale.

By embedding rights, licensing, and provenance directly into the data collection process, Numo ensures that datasets are not only high-quality, but also usable in production AI systems without uncertainty around ownership or compliance.

From IP Strategy’s perspective, Numo demonstrates how real-world data can become a scalable, rights-cleared asset class, enabling the next generation of AI systems to be trained on verifiable, commercially usable data.

IP Strategy expects to continue highlighting ecosystem developments that expand the supply of high-value data, support compliant AI systems, and drive long-term adoption of programmable intellectual property infrastructure.

About IP Strategy

IP Strategy Holdings, Inc. (Nasdaq: IPST) is the first Nasdaq-listed company to hold $IP tokens as a primary reserve asset and operate a validator for the Story Blockchain. The Company provides public market investors broad exposure to the $80 trillion programmable intellectual property economy in a regulated equity format. IP Strategy’s treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.

About Story

Story is the AI-native blockchain network powering the $IP token and making intellectual property programmable, traceable, and monetizable in real time. Backed by $136 million from a16z crypto, Polychain Capital, and Samsung Ventures, Story launched its mainnet in February 2025 and has rapidly become a leading infrastructure for tokenized intellectual property. Story allows creators and enterprises to turn media, data, and AI-generated content into legally enforceable digital assets with embedded rights, enabling automated licensing and new markets for intellectual property across AI and entertainment.

Forward-Looking Statements

This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, but are not limited to, those relating to Numo’s potential, including accelerated participation on the platform, the expected introduction of additional languages and data collection tasks and its ability to ensure that datasets are high-quality and usable in production AI systems without uncertainty around ownership or compliance, its potential to enable the next generation of AI systems to be trained on verifiable, commercially usable data and IP Strategy’s expectations to continue highlighting ecosystem developments that expand the supply of high-value data, support compliant AI systems, and drive long-term adoption of programmable intellectual property infrastructure.

Any forward-looking statements in this press release are based on IP Strategy’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the volatility of the Company’s common stock and any correlation between the Company’s stock price and the price of $IP tokens or any correlation between the Company’s stock price and activity or projects within the Story ecosystem, the legal, commercial, regulatory and technical uncertainty regarding digital assets generally, and expectations with respect to future performance and growth. These and other risks concerning IP Strategy’s programs and operations are described in additional detail in its latest annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and any other subsequent filings with the Securities and Exchange Commission. IP Strategy explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Investor Relations Contact:


[email protected]